Tandem Diabetes Care Inc (TNDM) Institutional Holdings & 13F Data (Q2 2026)

TNDM ranks #2296 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

277 institutions disclose a position in TNDM, but none treat it as a major bet — even Paradice Investment Management LLC, its most concentrated holder, allocates just 4.9% of its own portfolio to it.

Banque Pictet & Cie SA has trimmed its TNDM position for two straight quarters, cutting it by $801.7K while still holding $1.6M.

TNDM is up 2.1% today, and institutions have been net buyers of $106.0M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

TNDM reported a net loss of $63.3M over the trailing twelve months.

• Not yet profitable — net loss of $63.3M over the trailing twelve months
• Revenue grew 4.0% year over year
• Net income improved year over year, from -$205.5M to -$63.3M
• Operating cash flow was negative, using $9.7M in cash
• Current ratio of 2.55x — enough short-term assets to cover short-term liabilities
• Liabilities run 4.68x equity — a highly leveraged balance sheet worth noting